Stay updated on DeRIVE for Newly Diagnosed Myeloma Clinical Trial
Sign up to get notified when there's something new on the DeRIVE for Newly Diagnosed Myeloma Clinical Trial page.

Latest updates to the DeRIVE for Newly Diagnosed Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No visible changes to the study details or user-facing content were detected.SummaryDifference0.0%

- Check20 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page shows a revision update from v3.3.3 to v3.3.4 with no visible changes to study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations now lists Georgia as a study site. The page revision is updated to v3.3.3 and the Georgia Locations entry along with the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check91 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; no changes to study content, eligibility criteria, or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check99 days agoChange DetectedRemoved the government funding lapse notice from the page; this deletion does not affect the study details, eligibility criteria, or how a user interacts with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to DeRIVE for Newly Diagnosed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DeRIVE for Newly Diagnosed Myeloma Clinical Trial page.